Giga-tronics Incorporated
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GIGA research report →
Price Chart
About the company
Giga-tronics Incorporated, operating through its subsidiaries, specializes in the development and manufacturing of sophisticated electronic equipment tailored for military testing and airborne operational applications, serving both domestic and international markets. The company conducts its business through two distinct divisions: Microsource and the Giga-tronics Division. Its product portfolio includes microwave components; Band Reject Filters, vital for resolving interference issues in RADAR/Electronic Warfare (EW) systems; low-noise oscillators, which are integral to shipboard and land-based self-protection systems; and specialized RADAR filters designed for military fighter aircraft.
- CEO
- Jonathan R. Read
- IPO
- 1983
- Employees
- 7
- HQ
- Dublin, CA, US
Get TickerSpark's AI analysis on GIGA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $61.87K
- P/E
- -0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -3.31
- Div Yield
- 0.00%
- Gross Margin
- 28.01%
- Op Margin
- -54.13%
- Net Margin
- -58.63%
- ROE
- -110.62%
- ROIC
- -58.54%
Latest fiscal year · YoY change
- Revenue
- $30.25M+18.3%
- Gross Profit
- $8.47M+1.5%
- Op Income
- $-16,376,000
- Net Income
- $-17,738,000-471.1%
- EPS
- $-3.19-513.5%
- OCF Growth
- -59.5%
- FCF Growth
- -38.1%
- 52W High
- $0.24
- 52W Low
- $0.01
- 50D MA
- $0.05
- 200D MA
- $0.11
- Beta
- 3.79
- RSI (14)
- 34
- Avg Volume
- 10.76K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Giga-tronics posted a difficult fiscal 2022 with lower revenue and higher net loss, but highlighted a new DoD contract vehicle, an initial post-quarter TEmS order, and progress toward its Gresham combination.· June 29, 2022
- Fiscal 2022 revenue fell 31% to $9 million, driven mainly by a sharp drop in EW test revenue.
- Gross margin slipped to 36% for the year from 38%, and quarterly margin was 28% versus 30% a year ago.
- The company said it received a first IDIQ order after quarter-end for $783,000, which it sees as evidence of more normalized military order activity.
- Management expects the Gresham proxy to be filed in early August and the transaction to close in late August.
- CEO and CFO repeatedly pointed to scale and cost synergies from the combination, while acknowledging the company is still resource-constrained as a small public company.
For the fourth quarter of fiscal 2022, revenue was $1.4 million versus $2.7 million in the prior-year quarter, a 48% decline. Full-year fiscal 2022 revenue was $9 million compared with $13.1 million in fiscal 2021, down 31%. Q4 gross margin was 28% versus 30% a year ago, and full-year gross margin was 36% versus 38%. Q4 net loss was $1.2 million versus $0.8 million last year; full-year net loss was $2.7 million versus $390,000. Adjusted EBITDA loss was $740,000 in Q4 and $1.3 million for the year, versus losses of $610,000 and $0.5 million, respectively. Looking ahead, management did not give formal revenue guidance, but said it expects more normalized contract award activity in fiscal 2023 and expects to file the Gresham proxy in early August with closing in late August.
John Regazzi said the company’s two businesses have strong strategic fit with Gresham’s similar divisions, creating potential synergies in sales, R&D, and G&A. He framed the merger as a way to move beyond the limits of being a small public company and to build a larger platform that can grow both organically and inorganically. His tone was cautious on the quarter but upbeat about the combination and the longer-term opportunity.
Lutz Henckels described fiscal 2022 as “very disappointing,” with the main issue being weak EW test orders; that division generated only $770,000 of revenue versus $3.7 million in fiscal 2021. He noted gross margin pressure from product mix and lower revenue, operating expenses of $1.56 million in Q4 and $5.9 million for the year, and higher interest expense tied to the $800,000 BitNile affiliate loan. He also pointed to $1.2 million of additional inventory invested for TEmS and said stockholders’ equity fell from $4.2 million to $3.7 million, though debt and equity funding helped offset those investments.
Analysts focused on whether the new IDIQ contract was translating into sustained order activity, and management said multiple service branches and ranges are interested in replicating the capability and can now add task orders more easily. On the product side, management said the key advantages of the range application are reprogrammability and being a low-cost alternative, claiming the system is one-tenth the cost of competitors. On the Gresham deal, management said delays were caused by waiting on audited financial statements, but those have now been received, with the proxy expected in early August and closing in late August.
The positive case is that the company now has an IDIQ contract vehicle that should reduce procurement delays, and it already received a $783,000 post-quarter TEmS order. Management also said multiple branches and ranges are interested, suggesting broader demand beyond a single customer. The pending Gresham combination could add scale, synergies, and more resources for sales and R&D.
The quarter showed a steep revenue decline, with EW test revenue collapsing to $0.8 million for the year from $3.7 million, and the company remains dependent on uneven military procurement timing. Net loss widened materially, and adjusted EBITDA remained negative. Management also said the company is constrained as a small public company and has had to fund inventory investments and deal costs while waiting for larger orders to materialize.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 28.6%
- Shares Outstanding
- 7.93M
- Float Shares
- 2.27M
of shares held by institutions
1 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 15, 24 | Ault Alliance, Inc. | other | 2,000,000 |
| Jun 25, 24 | Ault Alliance, Inc. | buy | 5,000 |
| Jun 24, 24 | Ault Alliance, Inc. | buy | 5,000 |
| May 14, 24 | READ JONATHAN R | other | 12,492 |
| Nov 14, 23 | Shaffer Robin | other | 0 |
| Nov 14, 23 | Lyle Sean | other | 0 |
| Sep 19, 22 | BitNile Holdings, Inc. | buy | 100 |
| Sep 8, 22 | Bentz Jeffrey Allen | other | 0 |
| Sep 8, 22 | BitNile Holdings, Inc. | other | 4,250,000 |
| Sep 8, 22 | BitNile Holdings, Inc. | other | 4,250,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our GIGA coverage
Recent articles, reports, and earnings notes.
No research on GIGA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GIGA report →Stage 2 Geophysical Program Identifies Multiple Exploration Targets in Attic Zone at Giga Metals' Turnagain Project
newsfilecorp.com · Oct 8
Head to Head Review: Evolv Technologies (NASDAQ:EVLV) versus Giga-tronics (OTCMKTS:GIGA)
defenseworld.net · Aug 13
Giga-tronics (OTCMKTS:GIGA) Shares Cross Above 200-Day Moving Average – What’s Next?
defenseworld.net · Feb 7
Giga Metals Corp. Presents in Existing Agency's Virtual Webinar Series
newsfilecorp.com · Nov 20
First Atlantic Nickel to Attend Benchmark Mineral Intelligence's GIGA USA 2025 Conference, Highlighting Atlantic Nickel Project's Smelter-Free Processing for North America's Critical Minerals Supply Chain
globenewswire.com · Jun 2
GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Advanced Solid Tumors
globenewswire.com · May 20
Gresham Worldwide Bookings for the Second Quarter of 2023 Exceed $10.2 Million
businesswire.com · Jul 19
Giga-tronics to Host First Quarter Conference Call on August 11, 2022
globenewswire.com · Aug 10
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.